Matthew Johnson Email and Phone Number
Matthew Johnson work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Matthew Johnson personal email
- Valid
Matthew Johnson phone numbers
I’ve been leading at the nexus of pharmaceutical commercialization, private equity, and healthcare strategy for 20 over years. I’m an innovative problem-solver and senior executive with full P&L responsibility and M&A experience in multiple business models. I’m able to drive strategic decisions quickly through collaboration with key stakeholders and understanding metrics and analytics. I have scaled leadership from startups to multi-billion-dollar revenue businesses. I thrive in an environment where my intellect, integrity, commitment and ability to get things done are valued. I work with private equity, venture capital, and startups as a leader, board member, advisor, consultant, operating partner, and strategist.KEY ACCOMPLISHMENTS & CURRENT ROLES• Managing Partner - Ingenium Global• Board Member - BioCare SD• Board Member - Ally GPO• Board Member - PRO-Spectus• President and Board Member - VHS Logitech USA• Advisor - Panther Rare Pharmacy• Advisor - Dr Owl• Board Member - Access Infusion CareCritical Skills: Leadership, Strategy, Executive Management, Investment Board, M&A, Pharmaceutical Industry, Private Equity, P&L, Revenue Growth, Valuation, Venture Capital, Healthcare IT and Supply Chain Integrity.Areas Supported: Clinical trial support companies, health economics and outcomes research (HEOR), rare and orphan diseases, pharmaceutical distribution, Group Purchasing Organizations (GPOs - oncology and ophthalmology), patient services (HUB providers), third party logistics providers (3PL), specialty pharmacies, compounding pharmacies, infusion clinics, home infusion, CDMO, pharmaceutical sampling, and drug importation.Roles Fulfilled: Lead Director, Board Member, Advisory Board, CEO, M&A, Managing Partner, President, Consultant, Strategist, Operating Partner.Previously at AmerisourceBergen: • Tripled revenue with the #1 market-share in the health system and specialty pharmacy classes of trade for oncology, dialysis and blood derivatives.• Grew operating income six-fold.• Reduced business unit operating expenses from 48% to 21% of gross profit.• Grew business in new therapeutic areas such as oncology to leverage cost and capital structure.• Transformed committed capital from consuming to generating.• Led the complete acquisition process for 20+ deals to add to the core, add adjacent businesses, enter new geographies and markets, and accelerate innovation.I believe in empowering people and trusting them to do their jobs. I incentivize the right behaviors and create systems to reinforce them rather than just chasing metrics.
Access Infusion Care
View-
Board MemberAccess Infusion Care May 2024 - PresentBoard member delivering exceptional infusion care to patients in underserved communities.https://accessinfusioncare.com/
-
Lead Independent DirectorPro-Spectus Jun 2023 - PresentHuntington Beach, California, UsLead Independent Director and Board member for the patient services (HUB) business uniquely able to handle the most complex therapies and highest touch services, handling reimbursement support, market access and patient reported outcomes.https://www.pro-spectus.com/ -
Board MemberAllygpo Nov 2022 - PresentBoard member for the leading high touch, community focused Group Purchasing Organization (GPO), focused on oncology and ophthalmology in the physician office.https://allygpo.com/ -
Advisory Board MemberPantherx Rare Pharmacy Aug 2022 - PresentPittsburgh, Pa, UsAdvisor to the leading rare and orphan pharmacy.https://www.pantherxrare.com/ -
Managing PartnerIngenium Global Consulting Jul 2019 - PresentDallas, Tx, Us• Provided Strategy Development, M&A Diligence, and Transaction Advisory Services for Private Equity Sponsors in Specialty Distribution, Physician Group Purchasing (Oncology, Ophthalmology, Specialty Pharmacy, Rare and Orphan Pharmacy, Third Party Logistics (3PL), HUB and Patient Services, Pharmaceutical Sampling, Home Infusion and Infusion Clinics, Clinical Trial Logistics and Compassionate Use, Government Stockpile Logistics, Gross-to-Net Disruption (importation and direct buy), Contract Manufacturing (CDMO), Nuclear, and Sterile Compounding (503B).• Work with private equity portfolio companies to benchmark the competitiveness of service offerings and explore new strategic directions and find M&A opportunities.• Built out a new business unit for a client in the third-party logistics (3PL) business.• Forged commercial partnerships between HUB/patient service providers and specialty pharmacies for non-commercial programs. • Created pharmaceutical commercialization, launch, and channel strategies for specialty pharmaceutical and biosimilar manufacturers. • Developed new Medicare Advantage service offerings for payers.• Created healthcare technology partnerships to enhance the performance and safety of the pharmaceutical supply chain in North America.• Secured provider and payer partnerships and investment capital for a startup HCIT company.• Prepared a generics Third Party Logistics (3PL) provider to enter the specialty market.• Assessed the competitiveness of a biosimilar manufacturer's portfolio as other manufacturers entered the market and reference products adjusted their strategies.Select Private Equity - Vistria Group, Shore Capital, NaviMed Capital, Linden Capital, Great Point Partners, Court Square, RC Capital, Flexpoint Ford, Ares Management, Excellere, Bain Capital, New Harbor Capital, Warburg Pincus, Blackstone, and Athyrium Capital. Select Clients - Nations Health, Knipper Health, LifeScience Logistics, Sendera, RainerMed, and Pharma Access. -
Board MemberBiocare Sd May 2022 - PresentBoard member at the leading specialty distributor and 3PL provider for specialty pharmaceuticals, rare and orphan diseases, and other complex therapies.https://biocaresd.com/ -
Advisory Board MemberDrowl Jun 2021 - PresentAdvisor working with founders to tailor services, forge partnerships and optimize data offerings in oncology, rare and orphan, and other specialty therapeutic areas to enhance the value of this leading patient data application.https://www.drowl.com/ -
PresidentVhs Logitech Usa Feb 2021 - Dec 2024President and Board member, launched the North American business unit, finalized the certification and validation of the technology, and forged the partnership with Akutratemp.https://www.vhslogitech.com/
-
Senior Vice President, Pricing & Business Development, Health Systems & Specialty Care SolutionsAmerisourcebergen Feb 2018 - Jul 2019Conshohocken, Pa, UsPromoted to Senior Vice President for Pricing & Business Development for this global leader in pharmaceutical distribution and services. Reported to Executive Vice President Health Systems and Specialty Care Solutions. Directed all businesses relating to health systems, specialty pharmacies and physician clinics across all therapeutic areas and distribution models.KEY ACCOMPLISHMENTS• Developed holistic systems to analyze and optimize economic performance while enhancing market competitiveness for 11 newly integrated service lines that previously served mutual customers independently.• Balanced demands of revenue, market-share, market segment, gross margin, payment terms, specialty mix, 340B (disproportionate share) volumes, generic compliance and working capital.• Reduced margin compression while equalizing differences between profit centers and pulling through additional business.Additional ABC corporate initiatives:• Led the integration of HD Smith’s specialty business (Smith Medical Partners) into ASD Healthcare, ICS and Besse Medical.• Provided analysis for ABC’s response to the diverse initiatives proposed in American Patients First, specifically modeling the International Pricing Index. -
Chief Operating Officer And General ManagerAsd Healthcare, Subsidiary Of Amerisourcebergen May 2012 - Feb 2018Carrollton, Texas, UsAs the COO and GM for ASD Healthcare, a subsidiary of AmerisourceBergen, led entire business, including operations, sales, marketing, finance, procurement, provider solutions, and customer service, securing significant gains in revenue and operating income. Supported shared services, fulfilling duties of President. Therapeutic areas covered included oncology, nephrology, IVIG, factor, albumin, flu, rare and orphan diseases, cell and gene therapies. Primary customers were health systems, 340b, specialty pharmacies, infusion clinics, physician offices and clinics.KEY ACCOMPLISHMENTSFinancial Acumen & Strategy• Tripled revenue with #1 market-share in the health system and specialty pharmacy classes of trade for oncology, dialysis and blood derivatives.• Grew operating income six-fold.• Reduced business unit operating expenses from 48% to 21% of gross profit.• Grew business in new therapeutic areas such as oncology to leverage cost and capital structure.• Transformed committed capital from consuming to generating.Collaborative & Innovative Problem Solving• Improved shared customer experience with increased connectivity between ASD and ABC Drug customers jointly handled on a common system.• Increased customer experience (CX) levels of top box (5 out of 5) satisfaction scores through intensive commitment to measuring what’s important and empowering people to get things done.• Increased employee engagement by 15%. -
Board MemberNovologix - Cvs Health Dec 2011 - Apr 2013Served as a Board Member for this leading provider of IT solutions that manages specialty drugs under a payer’s medical benefit. ABSG investment. KEY ACCOMPLISHMENTS• Provided AmerisourceBergen with a 9% return above its cost of capital on investment.• Structured emergency funding in form of convertible debt to provide needed working capital.• Supported management in securing a multi-million-dollar contract that ensured the turnaround.• Facilitated acquisition by CVS/Caremark.
-
Vice President - Strategy / Mergers And AcquisitionsAmerisourcebergen Specialty Group, Subsidiary Of Amerisourcebergen Dec 2003 - May 2012Conshohocken, Pa, UsAs VP, fulfilling the role of Operating Partner, led M&A and Strategy for the AmerisourceBergen Specialty Group (ABSG) portfolio of companies including business unit strategies, turnaround, data analytics, new service development and governmental lobbying to support and accelerate rapid growth. Therapeutic areas included oncology, nephrology, ophthalmology, urology, rheumatology, IVIG, factor, albumin, flu, rare and orphan diseases, cell and gene therapies. Customers included health systems, 340b, specialty pharmacies, infusion clinics, physician offices and clinics. Services provided included distribution, GPO, 3rd party logistics, specialty pharmacy, reimbursement support, consulting, pharmaceutical commercialization. Areas covered were the United States, Canada, Brazil, UK, Germany, China, and India.KEY ACCOMPLISHMENTS• Facilitated a period of rapid expansion—increasing revenue and operating profits more than twelvefold—by leading semi-annual strategic planning for entire portfolio of companies.• Acquired 10 businesses with budget of $1.2B+ to consolidate market positions, extend service line capabilities and expand geographic footprint of ABSG.• Created growth and enhanced operating strategies by working with all BUs to achieve planned performance targets, addressing each company’s unique market position and capabilities.• Divested 3 consistently underperforming businesses to mitigate ongoing losses.• Provided and presented data and analysis for governmental lobbying on Medicare modernization, competitive acquisition program, average sales price, prompt pay discount and generic shortages.
-
Director Global Mergers And AcquisitionsUnderwriters Laboratories Sep 2001 - Oct 2003Northbrook, Illinois, Us- Expanded beyond the U.S. to improve operating margins and increase customer intimacy.- Created a 3-year global strategy for mergers and acquisitions with a total budget of $200M.- Closed a $43M acquisition in Japan and a $33M joint venture in China to expand Asian footprint. -
Director International Business DevelopmentAsi Group Sep 1998 - Aug 2001Boca Raton, Florida, Us- Rescued a $46M failing acquisition to achieve positive EBITDA within 10 months.- Recruited and trained 26 new channel partners and integrators to open new markets in Asia, Europe and South America, increasing revenue and global service and sales capabilities.
Matthew Johnson Education Details
-
Northwestern UniversityMechanical Engineering -
Auburn UniversityBusiness
-
CaltechMechanical Engineering
Frequently Asked Questions about Matthew Johnson
What company does Matthew Johnson work for?
Matthew Johnson works for Access Infusion Care
What is Matthew Johnson's role at the current company?
Matthew Johnson's current role is BOARD MEMBER | ADVISOR | PRESIDENT | CEO | PRIVATE EQUITY | VENTURE CAPITAL | M&A | STRATEGIST | OPERATING PARTNER.
What is Matthew Johnson's email address?
Matthew Johnson's email address is ma****@****hoo.com
What is Matthew Johnson's direct phone number?
Matthew Johnson's direct phone number is +146936*****
What schools did Matthew Johnson attend?
Matthew Johnson attended Northwestern University, Auburn University, Caltech.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial